A phase 1/2 study evaluating the safety and efficacy of autologous TAC T cells in subjects with claudin 18.2(+)advanced solid tumors Meeting Abstract
| Authors: | Sohal, D.; Iqbal, S.; Turcotte, S.; Botta, G. P.; Schlechter, B. L.; Ku, G. Y.; Hosein, P. J.; Saibil, S.; Gavriliuc, M.; Apostolopoulou, M.; Giwa, M.; MacGregor, H.; Moss, K. M.; Panna, E.; Murugappan, S.; Dumbrava, E. E. |
| Abstract Title: | A phase 1/2 study evaluating the safety and efficacy of autologous TAC T cells in subjects with claudin 18.2(+)advanced solid tumors |
| Meeting Title: | 2025 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2025 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-06-01 |
| Start Page: | e14519 |
| Language: | English |
| ACCESSION: | WOS:001534474700001 |
| DOI: | 10.1200/JCO.2025.43.16_suppl.e14519 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
